Doctoral thesis
English

Evaluation of peptide drugs targeting mitochondria and the cyclic AMP pathway in the mdx mouse, a model for Duchenne muscular dystrophy

ContributorsReutenauer, Julie
DirectorsRuegg, Urs
Defense date2009-03-27
Abstract

Duchenne muscular dystrophy (DMD) is a severe muscular dystrophy, which affects approximately 1 out of 3500 male births. Starting in early childhood, the disease is characterized by progressive muscle wasting, and associated with respiratory complications and cardiac dysfunction leading to death by age 20-30. DMD is caused by the absence of the cytoskeletal protein dystrophin that is encoded by the X-chromosome (Xp21). Dystrophin is a large protein that links the extracellular matrix via a transmembrane complex of glycoproteins to the intracellular F-actin network. This ensures mechanical stability to muscle cells during contraction. Lack of dystrophin leads to muscle cell death accompanied by chronic inflammation...

Keywords
  • Dystrophie musculaire
  • Pharmacothérapie
  • AMP cyclique
  • Pore mitochondrial de perméabilité transitoire
Citation (ISO format)
REUTENAUER, Julie. Evaluation of peptide drugs targeting mitochondria and the cyclic AMP pathway in the mdx mouse, a model for Duchenne muscular dystrophy. Doctoral Thesis, 2009. doi: 10.13097/archive-ouverte/unige:2226
Main files (1)
Thesis
accessLevelRestricted
Identifiers
879views
0downloads

Technical informations

Creation02/07/2009 11:02:00
First validation02/07/2009 11:02:00
Update14/03/2023 15:09:37
Status update14/03/2023 15:09:37
Last indexation13/05/2025 15:37:13
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack